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Abstract
Background: Magnetic resonance imaging studies of cigarette smoking-related effects on 
human brain structure have primarily employed voxel-based morphometry, and the most 
consistently reported finding was smaller volumes or lower density in anterior frontal regions and 
the insula. Much less is known about the effects of smoking on subcortical regions. We compared 
smokers and non-smokers on regional subcortical volumes, and predicted that smokers 
demonstrate greater age-related volume loss across subcortical regions than non-smokers.
Methods: Non-smokers (n = 43) and smokers (n = 40), 22–70 years of age, completed a 4 T MRI 
study. Bilateral total subcortical lobar white matter (WM) and subcortical nuclei volumes were 
quantitated via FreeSurfer. In smokers, associations between smoking severity measures and 
subcortical volumes were examined.
Results: Smokers demonstrated greater age-related volume loss than non-smokers in the bilateral 
subcortical lobar WM, thalamus, and cerebellar cortex, as well as in the corpus callosum and 
subdivisions. In smokers, higher pack-years were associated with smaller volumes of the bilateral 
amygdala, nucleus accumbens, total corpus callosum and subcortical WM.
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Conclusions: Results provide novel evidence that chronic smoking in adults is associated with 
accelerated age-related volume loss in subcortical WM and GM nuclei. Greater cigarette quantity/
exposure was related to smaller volumes in regions that also showed greater age-related volume 
loss in smokers. Findings suggest smoking adversely affected the structural integrity of subcortical 
brain regions with increasing age and exposure. The greater age-related volume loss in smokers 
may have implications for cortical-subcortical structural and/or functional connectivity, and 
response to available smoking cessation interventions.
Keywords
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1. Introduction
The relationship between cigarette smoking and risk for cardiac, pulmonary and vascular 
disease as well as for multiple forms of cancer in humans is essentially incontrovertible 
(CDC, 2004). Moreover, considerable recent evidence now links smoking, in otherwise 
healthy individuals, to significant neurobiological and neurocognitive abnormalities that are 
not specifically attributable to the above diseases (Azizian et al., 2009; Durazzo et al., 
2014a; Durazzo et al., 2010; Sharma and Brody, 2009). Macrostructural morphological 
abnormalities are the most consistently reported neurobiological consequence associated 
with chronic cigarette smoking (Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 
2016). Most magnetic resonance (MR) imaging studies investigating smoking-related 
changes in brain morphology focused on cortical gray matter (GM) volumes, and smaller 
volumes or lower density in anterior frontal regions and the insula were most consistently 
reported finding [see (Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 2016) for 
review]. Fewer studies described smoking-related effects on subcortical nuclei/region 
volumes. Older adult smokers (≥64 years of age) had decreased thalamic volume relative to 
non-smokers (Almeida et al., 2008). Young-to-middle aged otherwise healthy smokers, 
compared to non-smokers, demonstrated smaller volumes or lower density in the thalamus 
(Franklin et al., 2014; Liao et al., 2012), globus pallidus (Hanlon et al., 2016), and 
cerebellum (Brody et al., 2004; Franklin et al., 2014; Gallinat et al., 2006; Kuhn et al., 2012; 
Wetherill et al., 2015; Yu et al., 2011). Conversely, some studies indicated that young-to-
middle-aged adult smokers had larger volumes than non-smokers in the putamen (Franklin 
et al., 2014; Wetherill et al., 2015; Yu et al., 2011). Subcortical neurobiological 
abnormalities may underlie compulsive consumption in substance use disorders, including 
nicotine dependence (see Franklin et al., 2014 and references cited therein). In the above 
studies, voxel-based morphometry compared GM density or volume between smokers and 
non-smokers. While this approach allowed testing for the effect of smoking status (i.e., 
smoker vs. non-smoker) collapsed across the age range of the participants, only one study 
(Franklin et al., 2014) specifically tested for, but did not observe, a smoking status by age 
interaction.
The risk for smoking-related diseases increases with years of smoking (CDC, 2004), which 
is inextricably related to age. In healthy adults, increasing age is associated with declines in 
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multiple MR-based measures, including regional brain volumes (Crivello et al., 2014; 
Walhovd et al., 2011), brain metabolite levels (Chang et al., 2009), as well as neurocognition 
(Salthouse, 2000). In healthy participants 25–70 years of age, our previous MR imaging 
studies showed that smokers had both lower mean values and greater age-related declines in 
total hippocampal and hippocampal subregion volumes (Durazzo et al., 2013); we also 
observed similar age-related declines in anterior frontal brain metabolite (N-acetylaspartate 
and glutamate) concentrations (Durazzo et al., 2016c). In these studies, greater cigarette 
pack-years were related to smaller hippocampal volumes and lower metabolite levels. The 
greater age-related declines apparent in smokers suggest that chronic smoking amplified the 
effects of normal aging on hippocampal macrostructure and anterior frontal brain metabolite 
levels in our adult participants. Given that previous subcortical morphological studies did not 
specifically test for, or report, a smoking status by age interaction, it remains unclear if 
cigarette smoking is associated with more widespread subcortical volume loss with 
increasing age in adults. Such structural alterations may be clinically important because they 
could influence reward processing and response to smoking cessation interventions via 
alterations of structural and/or functional connectivity in frontolimbic and/or frontostriatal 
circuitry (Froeliger et al., 2015; Sutherland et al., 2016; Sweitzer et al., 2016). Based on our 
previous neuroimaging findings, we predicted that adult smokers demonstrate smaller mean 
volumes and greater age-related volume loss than non-smokers in the thalamus, cerebellum, 
brainstem, total subcortical lobar white matter, and basal ganglia nuclei. We predicted higher 
pack-years are related to smaller regional subcortical volumes in smokers.
2. Methods
2.1. Participants
Eighty-three healthy, community-dwelling participants [43 non-smokers (eight females) and 
40 smokers (five females)] were recruited via electronic billboards and word-of-mouth. 
Participants were between the ages of 22 and 70 (see Table 1 for demographics). Participants 
provided written informed consent according to the Declaration of Helsinki, and all 
procedures were approved by the University of California San Francisco and the San 
Francisco VA Medical Center.
Detailed inclusion/exclusion criteria are fully described elsewhere (Durazzo et al., 2011a). In 
summary, participants were screened for history of neurologic (e.g., seizure disorder, 
neurodegenerative disorder, demyelinating disorder, closed head trauma with loss of 
consciousness), general medical (e.g., hypertension, myocardial infarction, Type-1 or 2 
diabetes, cerebrovascular accident, any form of cancer), and psychiatric (i.e., mood, thought, 
anxiety, substance/alcohol use disorders) conditions known or suspected to influence 
neurocognition and/or brain neurobiology. All females were pre-menopausal, by self-report. 
All non-smoking participants never smoked, or smoked less than 40 cigarettes during their 
lifetime and used no cigarette/tobacco products for 10 years prior to study. All smoking 
participants were actively smoking at the time of assessment, smoked at least 10 cigarettes 
per day for 5 years or more, and had no periods of smoking cessation greater than 1 month 
in the 5 years prior to study, with no concurrent use of other tobacco products. No smoker 
was engaged in any pharmacological/behavioral smoking cessation program.
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2.2. Medical, psychiatric, substance, alcohol consumption assessment
Participants completed the screening section of the Structured Clinical Interview for DSM-
IV Axis I disorders, Patient Edition, Version2.0 [SCID-I/P; (First et al., 1998)], as well as an 
in-house questionnaire designed to screen for medical, psychiatric, neurological and 
developmental conditions that may affect neurocognition or neurobiology [see (Durazzo et 
al., 2004)]. Participants completed standardized questionnaires assessing lifetime alcohol 
consumption [Lifetime Drinking History, LDH; (Skinner and Sheu, 1982; Sobell et al., 
1988)] and substance use [in-house questionnaire assessing substance type, quantity and 
frequency of use (Abe et al., 2013)]. From the LDH, we derived average number of drinks 
per month over lifetime (one drink defined as containing 13.6 g of pure ethanol). 
Participants also completed self-report measures of depressive [Beck Depression Inventory, 
BDI; (Beck, 1978)] and anxiety symptomatology [State-Trait Anxiety Inventory, form Y-2, 
STAI; (Spielberger et al., 1977)]. Smokers completed a measure of nicotine dependence 
level [Fagerström Test for Nicotine Dependence (FTND; Heatherton et al., 1991)], self-
reported the number of cigarettes currently smoked per day, and the number of years of 
smoking over lifetime. Pack-years [(number of cigarettes per day/20) × total number of 
years of smoking] were calculated for smokers. Comparable frequencies of smokers and 
non-smokers (30%) reported intermittent “recreational” use (i.e., ≤3 episodes/month) of 
cannabis or cocaine during late adolescence or early adulthood. Prior to assessment, 
participants’ urine was tested for five common illicit substances (i.e., THC, opiates, PCP, 
cocaine, amphetamines), and participants were breathalyzed for recent ethanol consumption. 
No participant was positive for the above common illicit substances or ethanol at the time of 
assessment.
2.3. Magnetic resonance imaging (MRI) acquisition and processing
MRI data were acquired on a 4.0 T Bruker MedSpec system using an 8-channel transmit-
receive head coil (Siemens, Erlangen, Germany). A Magnetization Prepared Rapid Gradient 
(TR/TE/TI = 2300/3/950 ms, 7° flip angle, 1.0 × 1.0 × 1.0 mm3 resolution) sequence was 
used to acquire 3D sagittal T1-weighted images for morphological analyses. The publicly 
available FreeSurfer (v5.1) segmentation and cortical surface reconstruction methods were 
used to obtain regional, bilateral cortical, subcortical GM and total subcortical lobar white 
matter (WM) volume, and total intracranial volume (ICV) (all in mm3) (Dale et al., 1999; 
Fischl and Dale, 2000; Fischl et al., 2004, 1999). All segmented subcortical and parcellated 
cortical T1-weighted images were visually inspected by one of the authors (TCD) for 
accuracy; any errors in segmentation/parcellation were manually edited, reprocessed and 
again inspected as previously described (Durazzo et al., 2014c). The final segmented 
subcortical and parcellated cortical volumes passed all quality requirements (Durazzo et al., 
2011b). The subcortical regions of interest (ROIs) interrogated were the total bilateral 
subcortical lobar WM, bilateral thalamus, caudate, putamen, pallidum, amygdala, nucleus 
accumbens, cerebellar cortex and cerebellar WM. Midline ROIs included the brain stem as 
well as the total corpus callosum volume and corpus callosum subregions (anterior, mid-
anterior, central, mid-posterior, and posterior). Individual ROI volumes were scaled to their 
corresponding ICV and reported as the percentage of ICV.
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2.4. Statistical analyses
2.4.1. Demographic and clinical variables—Demographic and clinical variables 
were compared between smokers and non-smokers with t-tests and Fisher’s Exact Test, 
where indicated
2.4.2. Primary analyses—To test our hypothesis of greater age-related subcortical 
volume loss in smokers versus non-smokers, we employed generalized linear modeling 
(GENLIN), and specifically tested for a smoking status (smoker vs. non-smoker) by age 
interaction. In preliminary analyses comparing smokers and non-smokers, similar magnitude 
group differences were observed for the left and right hemisphere of bilateral regions/nuclei; 
therefore, results for the summed volumes of bilateral ROIs are presented. Additionally, 
group differences across corpus callosum sub-regions were highly consistent; thus results for 
the total corpus callosum volume are only reported. Dependent measures were ROI volumes 
(percent of ICV), and covariates included BDI and average lifetime drinks/month (smokers 
and non-smokers were different on these measures; see Table 1 and 3.1 below). Significant 
univariate effects for smoking status were followed-up with t-tests (two-tailed). Although we 
predicted a priori that smokers exhibit smaller subcortical volumes, we adopted a 
conservative approach and corrected the t-test alpha level (p = 0.05) for multiplicity of tests 
with a modified Bonferroni method (Sankoh et al., 1997), based on 11 ROIs and the inter-
correlations among ROIs for all participants (r = 0.63). This produced an adjusted two-tailed 
alpha level of p < 0.022 for post-hoc t-tests for each ROI. Interactions between smoking 
status and age were considered significant at p < 0.05. Effect sizes for statistically significant 
differences in mean volume between smokers and non-smokers were calculated with 
Cohen’s d (Cohen, 1988).
2.4.3. Exploratory analyses—Statistically significant smoking status × age 
interactions were further explored via a median split on age, which divided the sample into 
four groups: younger non-smokers and smokers (22–45 years of age; mean age of 35 years), 
and older non-smokers and smokers (46–70 years of age; mean age of 55 years). Younger 
non-smokers (n = 24) and younger smokers (n = 17) were not different on any clinical or 
demographic variable. Older non-smokers (n = 19) and older smokers (n = 23) were 
equivalent on clinical and demographic variables, except that older smokers had fewer years 
of education.
Two exploratory analyses were conducted on the basis of the age median split for ROIs 
showing a significant smoking status × age interaction in the Primary Analyses: 1) Slopes of 
volume across age were statistically compared among the four groups via GENLIN, and 
group differences on slopes were considered statistically significant at p < 0.05. 2) Mean 
ROI volumes were compared across the four groups. Main effects, interactions and pairwise 
t-tests (two-tailed; providing comparisons of mean volumes among the four groups) were 
considered statistically significant at p < 0.05. Comparisons of slopes and mean volumes 
between younger smokers and non-smokers were adjusted for age because of the established 
relationship between age and regional brain volumes. Comparisons of slopes and mean 
volumes among older smokers and non-smokers were adjusted for age and education; 
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comparisons of slopes and mean volumes between younger and older smokers were adjusted 
for pack-years.
2.4.4. FTND score—Associations between the 11 ROI volumes and cigarette pack-years 
(measure of exposure magnitude) and FTND score (measure of nicotine dependence level) 
were examined with linear regression; part (semi-partial) correlations were reported, 
adjusting for age and lifetime average drinks/month. Although we predicted that higher 
pack-years in smokers are inversely related to all subcortical volumes, we corrected the 
alpha level (p = 0.05) for the part correlations for multiplicity of tests with the above 
described modified Bonferroni procedure; a two-tailed p < 0.022 was considered statistically 
significant.
3. Results
3.1. Participant demographics and clinical variables
Smokers and non-smokers were equivalent on age, sex, percent of Caucasians, level of 
anxiety symptomatology and education (see Table 1). Smokers had significantly higher BDI 
scores, and consumed more average drinks per month over lifetime (all p < 0.05). Although 
statistically different between groups, the average BDI score for both groups was in the 
normal range (i.e., < 10) and well below the cutoff for mild depressive symptomatology 
(Richter et al., 1998). Participant alcohol consumption did not approach a hazardous level 
[see (McKee et al., 2007; Mertens et al., 2005)].
3.2. Primary analyses: main effects and interactions for smoking status and age
Significant smoking status × age interactions were observed for volumes of the total 
subcortical WM [χ2(1) = 4.40, p = 0.036], total corpus callosum [χ2(1) = 4.50, p = 0.034], 
thalamus [χ2(1) = 4.29, p = 0.038], and cerebellar cortex [χ2(1) = 4.61, p = 0.032]; in these 
regions, smokers showed significantly greater volume loss with increasing age than non-
smokers (see Figs. 1 and 2). Smokers also showed trends for greater age-related volume loss 
in the brainstem (p = 0.08) and caudate (p = 0.10) Except for the pallidum, cerebellar WM 
and brain stem, age was inversely related to volumes in all other ROIs (all p < 0.01). Greater 
lifetime average drinks/month, although low, was associated with smaller total corpus 
callosum volume (p = 0.018). No main effects were observed for smoking status in any ROI 
(all p > 0.12). Findings were essentially unchanged when female participants were removed 
from the analyses. The greater volume loss in smokers in the above regions was similar in 
the left and right hemispheres in bilateral ROIs (data not shown).
3.3. Exploratory analyses comparing younger and older groups
3.3.1. Comparisons of slopes of volume across younger smokers and non-smokers, as well 
as older smokers and non-smokers were conducted with GENLIN for the subcortical WM, 
total corpus callosum, thalamus, and cerebellar cortex, regions in which smokers showed 
greater age-related volume loss in our Primary Analyses. Older smokers showed greater age-
related volume loss than younger non-smokers in the subcortical WM (β = −0.39, p = 
0.021), total corpus callosum (β = −0.05, p = 0.014), and cerebellar cortex (β = −0.11, p = 
0.046). Older non-smokers had greater age-related volume loss than younger non-smokers in 
Durazzo et al. Page 6
Drug Alcohol Depend. Author manuscript; available in PMC 2019 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the total corpus callosum (β = −0.04, p = 0.020). No other group differences were observed 
(see Figs. 3–6 ). Both older smokers and non-smokers showed moderate strength 
associations between age and subcortical WM, total corpus callosum, and thalamus volumes, 
while both younger non-smokers and smokers demonstrated very weak associations between 
age and volumes of all ROIs.
3.3.2. Smoking status (smokers vs. non-smokers) × age group (older vs. younger 
participants) interaction GENLIN models were conducted for the subcortical WM, total 
corpus callosum, thalamus, and cerebellar cortex, where smokers showed greater age-related 
volume loss in the Primary Analyses. Main effects of age group (younger vs. older) were 
observed for the total corpus callosum [χ2(1) = 4.24, p = 0.039], thalamus [χ2(1) = 9.43, p = 
0.002], cerebellar cortex [χ2(1) = 13.25, p < 0.001] and a trend for subcortical WM [χ2(1) = 
3.71, p = 0.054], where the younger participants had larger volumes than the older 
participants. No significant main effects were observed for smoking status (all p > 0.051). 
Trends for a smoking status × age group interaction were observed for the total corpus 
callosum (p = 0.055) and thalamus (p = 0.062), which were driven by smaller mean volumes 
in older smokers. Pairwise t-tests indicated older smokers had smaller volumes than younger 
and older non-smokers in the above four ROIs, and smaller volumes than younger smokers 
in the total corpus callosum, thalamus, and cerebellar cortex (all p < 0.05). No other 
significant mean volume differences were observed (see Table 2). In comparisons between 
older smokers and older non-smokers, greater age was related to smaller subcortical WM, 
total corpus callosum, and thalamic volumes (all p < 0.01), but education was not associated 
with any volume (all p > 0.50). Age was not related to volumes in comparisons between 
younger smokers and younger non-smokers (all p > 0.40).
3.4. Associations of pack-Years and FTND with regional subcortical volumes in smokers
In smokers, higher pack-years showed significant negative associations of moderate strength 
with the volumes for total amygdala (see Fig. 7), nucleus accumbens, total corpus callosum 
and subcortical WM after adjusting for age and lifetime average drinks/month (see Table 3); 
the magnitudes were generally similar for bilateral structures (data not shown). A higher 
FTND score was associated with lower total corpus callosum volume (r = −0.37, p = 0.007) 
after adjusting for age and lifetime average drinks/month in smokers; no other significant 
associations between FTND and subcortical volumes were observed. The magnitudes and 
directions of the associations between pack-years, FTND and volumes across ROIs for 
younger and older smokers were largely equivalent.
4. Discussion
The primary findings of this 4 T quantitative MRI study were: 1) Otherwise healthy adult 
smokers demonstrated greater age-related volume loss than non-smokers in the bilateral and 
total (sum of left and right hemisphere) subcortical WM, thalamus, and cerebellar cortex, as 
well as the total corpus callosum; 2) Older smokers showed significantly smaller volumes 
than younger and older non-smokers in the subcortical WM, corpus callosum, thalamus and 
cerebellar cortex, as well as smaller volumes than younger smokers in the corpus callosum, 
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thalamus, and cerebellar cortex; 3) In smokers, greater pack-years were associated with 
smaller amygdala, nucleus accumbens, corpus callosum and subcortical WM volumes.
The greater age-related volume loss in smokers was pronounced in the total lobar WM and 
corpus callosum. The thalamus and cerebellar cortex were the only subcortical GM ROIs 
that showed statistically significant greater age-related volume loss in smokers. Comparisons 
of slopes of volumes across age between younger and older participants suggested the 
greater age-related volume loss observed in smokers in the above regions was primarily 
driven by significantly larger volume loss with age in older smokers relative to younger non-
smokers. Correspondingly, older smokers were the only group to show significant 
associations between age and subcortical WM, corpus callosum, thalamus and cerebellar 
cortex volume. There were no significant differences among smokers and non-smokers, as a 
whole, on any ROI volume. However, older smokers had smaller total lobar WM, corpus 
callosum, thalamus and cerebellar cortex volumes than younger non-smokers, younger 
smokers and older non-smokers; the largest magnitude differences were between younger 
non-smokers and older smokers, reflecting the interacting effects of age and smoking status 
on these regions. No significant differences were observed between younger non-smokers, 
younger smokers and older non-smokers; the effect sizes from these comparisons were 
generally weak, indicating the lack of differences between these groups was not a function 
of inadequate power related to group size.
A central mechanism hypothesized to be related to the neurobio-logical abnormalities 
observed in smokers is increased brain oxidative stress (OxS) that is promoted by elevated 
free radical species and decreased endogenous antioxidant levels (Durazzo et al., 2014a; 
Swan and Lessov-Schlaggar, 2007). The gas and particulate phases of cigarette smoke have 
extremely high concentrations of short-and-long-lived free radical species and other 
oxidizing agents (Ambrose and Barua, 2004; Valavanidis et al., 2009). In addition to 
increased free radical levels, smoking is associated with markedly elevated 
carboxyhemoglobin levels (Deveci et al., 2004), altered mitochondrial respiratory chain 
function (Alonso et al., 2004), and induction of proinflammatory cytokine release by 
peripheral and central nervous system glial cells (Mazzone et al., 2010), which combine to 
further escalate cerebral OxS. It is well established that OxS is directly associated with 
damage to membrane lipids, proteins, carbohydrates, DNA and RNA of neuronal, glial, and 
vascular tissue of the brain [see (Durazzo et al., 2014a) and references therein]. 
Oligodendrocytes (the myelin-producing cells of the brain), granular neurons of the 
cerebellar cortex, and neurons in several hippocampal subregions are highly susceptible to 
OxS (Smith et al., 1999; Wang and Michaelis, 2010). While not universally accepted [see 
(Salmon et al., 2010)], increasing OxS burden with aging is suggested to be a fundamental 
mechanism contributing to neurodegeneration in normal aging (Halliwell, 2006; Zimniak, 
2011). We previously observed that current and former cigarette smoking in cognitively 
normal elders (Durazzo et al., 2016a, 2014b) and current smoking in those with probable 
Alzheimer disease (Durazzo et al., 2016a) are associated with significantly elevated 
cerebrospinal fluid isoprostane concentration, which is a biomarker of increased central 
nervous system OxS. In these groups of elders (76 ± 6 years of age), higher isoprostane 
concentration was related to smaller hippocampal volume. Consistent with this relationship, 
young-to-older adult smokers showed greater age-related volume loss than non-smokers in 
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the total hippocampus and several hippocampal subregions (Durazzo et al., 2013). In the 
current study, adult smokers, as a whole, exhibited greater age-related volume loss in the 
lobar WM and across the entire corpus callosum; however, the results of the exploratory 
analyses suggested this effect was largely driven by the older smokers (46–70 years of age). 
Collectively, our findings in young-to-elder adults suggest the chronic OxS imposed by 
cigarette smoking may interact with the OxS associated with normal aging, which may 
amplify degeneration in subcortical brain regions that are either highly vulnerable to OxS 
(e.g., lobar sub-cortical WM, hippocampus) and/or have a high metabolic activity (e.g., 
cerebellar cortex, hippocampus, and thalamus).
Greater cigarette pack-years in smokers were associated with smaller amygdala, nucleus 
accumbens, total corpus callosum and sub-cortical lobar WM volumes, while higher level of 
nicotine dependence was only related to smaller corpus callosum volume. This pattern 
suggests that greater amount/duration of cigarette exposure rather than nicotine dependence 
level was related to smaller tissue volume in most subcortical regions, consistent with 
findings for cortical volumes/density (Durazzo et al., 2010; Pan et al., 2013; Sutherland et 
al., 2016). Subregions of the amygdala (Mineur et al., 2016) and nucleus accumbens (Crespo 
et al., 2006) have a high density of cholinergic receptors, but is it is not clear if the chronic 
upregulation and decreased sensitivity of nicotinic receptors associated with nicotine 
dependence is related to the morphological integrity of these tissue. Additionally, as the 
FTND is an ordinal metric of limited range, it may not be as robust a predictor as pack-
years.
This study has limitations that may affect the generalizability of our findings. Although 
smokers demonstrated greater age-related volume loss in several ROIs, a longitudinal design 
is required to verify the findings of this cross-sectional study. The formation of the older and 
younger groups was based on a median split of the participants’ age range, yielding groups 
above and ≤45 years of age. Consequently, our operationalization of older and younger 
groups, and the corresponding volumetric findings, should be considered preliminary. 
Undocumented premorbid/comorbid group differences in lifestyle or subclinical biomedical 
conditions (e.g., diet/nutrition, exercise, subclinical pulmonary or cardiovascular 
dysfunction) and/or genetic polymorphisms (Mon et al., 2013) may have influenced the 
results. Since this study excluded individuals with clinically significant smoking-related 
morbidity, it is possible that the age-related effects were underestimated in this healthy 
cohort (Durazzo et al., 2014a). Additionally, given the subcortical lobar WM was not further 
divided into major lobes, further investigation needs to examine any regional specificity of 
age-related WM volume loss in smokers. Finally, the small number of females precluded 
assessment of sex effects.
5. Conclusions
The study results provide novel evidence that cigarette smoking is associated with 
accelerated age-related volume loss in multiple sub-cortical brain regions. The findings also 
suggested the smoking-related effects on subcortical WM and GM regions/nuclei were most 
apparent in the older age group, starting at 46 years of age in this cohort. These data offer 
further insight into the potential neurobiological substrates related to the neuropsychological 
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abnormalities observed in cigarette smokers across adulthood (Durazzo et al., 2016b, 2010), 
and may have implications for cortical-subcortical structural and functional connectivity in 
smokers with increasing age. Why are these findings and continued research on the 
neurobiological consequences of smoking clinically relevant? The fundamental reasons are 
that over 1 billion people worldwide are cigarette smokers, and smoking-related diseases kill 
at least 6 million individuals annually (WHO, 2015). Understanding the effects of chronic 
smoking on brain micro-and-macrostructural integrity, biochemistry, functional and 
structural connectivity, as well as their functional correlates is required to inform the 
development of more effcacious smoking cessation interventions (Addicott et al., 2014, 
2015; Durazzo et al., 2014a, 2016c, 2015).
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Fig. 1. 
(A) Subcortical lobar white matter volume across age for Non-smokers and Smokers. (B) 
Total corpus callosum volume across age for Non-smokers and Smokers.
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Fig. 2. 
(A) Thalamus volume across age for Non-smokers and Smokers. (B) Cerebellar cortex 
volume across age for Non-smokers and Smokers.
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Fig. 3. 
Subcortical lobar white matter volume across age for Younger and Older groups.
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Fig. 4. 
Total corpus callosum volume across age for Younger and Older groups.
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Fig. 5. 
Thalamus volume across age for Younger and Older groups.
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Fig. 6. 
Cerebellar cortex volume across age for Younger and Older groups.
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Fig. 7. 
Association of amygdala volume with pack-years.
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Table 1
Group Demographics, Alcohol and Cigarette Use Histories, Mood Measures, and Intracranial Volume (ICV).
Measure; min-max Non-smokers (n = 43) Smokers(n = 40)
Age (years) 43 (13) 22–70 47 (11) 22–64
Education (years) 16 (2) 12–20 15 (2) 12–20
Male (%) 81 87
Caucasian (%) 60 70
Lifetime average drinks/month 19 (11) 1–54 26 (14) 3–56*
FTND NA 5 (2) 2–8
Pack-years NA 26 (16) 0.5–63
Age onset of smoking NA 16 (6) 13–24
BDI 3 (3) 0–13 6 (3) 0–13*
STAI 32 (7) 21–46 34 (9) 20–56
Intracranial volume (cc) 1409 (201) 972–1738 1477 (208) 828–1750
Note. BDI: Beck Depression Inventory. FTND: Fagerstrom Tolerance Test for Nicotine Dependence. Min: minimum. max: maximum. NA: not 
applicable. STAI: State −trait Anxiety Inventory − Trait.
*Smokers > Non-smokers, p < 0.05. Mean (SD).
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Table 3
Associations between Regional Volumes and Pack-Years in Smokers.
Region r p-value
Amygdala −0.49 0.001
Nucleus Accumbens −0.42 0.004
Total Corpus Callosum −0.38 0.006
Subcortical Lobar White Matter −0.35 0.016
Caudate −0.32 0.028
Putamen −0.26 0.049
Thalamus −0.25 0.09
Brain Stem −0.21 0.19
Pallidum −0.12 0.48
Cerebellar Gray Matter −0.07 0.65
Cerebellar White Matter −0.02 0.91
Note. r-values are part (semi-partial) correlations adjusted for age and lifetime average drinks/month; p < 0.022 is statistically significant.
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